7 research outputs found
Distribution of antibody responses to Bm14, Bm33, and Wb123 by school for TAS 1 (2011) and TAS 2 (2015) in American Samoa.
<p>Responses to Wb123 in TAS 1 were assessed by luciferase immunoprecipitation system (LIPS) assay. All other responses were assessed by multiplex bead assay.</p
Antibody test concordance among children with unknown antigen status in TAS 1 (February 2011) and TAS 2 (April 2015) in American Samoa.
<p>Antibody test concordance among children with unknown antigen status in TAS 1 (February 2011) and TAS 2 (April 2015) in American Samoa.</p
Median fluorescence intensity minus background (MFI-bg) values by school for the 22 schools included in both TAS 1 (February 2011) and TAS 2 (April 2015) in American Samoa.
<p>Minimum and maximum MFI-bg values within each school are indicated in parentheses.</p
Antibody test concordance among antigen negative children in TAS 1 (February 2011) and TAS 2 (April 2015) in American Samoa.
<p>Antibody test concordance among antigen negative children in TAS 1 (February 2011) and TAS 2 (April 2015) in American Samoa.</p
Distribution of antibody responses to Wb123, Bm14, and Bm33 in all elementary schools located on the main island of Tutuila in American Samoa.
<p>Responses to Wb123 in TAS 1 were assessed by LIPS. All other responses were assessed by multiplex bead assay.</p
All public and private elementary schools in American Samoa included in TAS 1 and TAS 2.
<p>Age and sex distribution of children enrolled in TAS 1 and TAS 2 and number of samples tested for circulating filarial antigen by ICT are summarized by survey year.</p
Additional file 1 of Geospatial analysis of Plasmodium falciparum serological indicators: school versus community sampling in a low-transmission malaria setting
Additional file 1: Table S1. Remote sensing data: resolutions, units, and sources. Table S2. Prevalence of positive rapid diagnostic test results with 95% confidence intervals by survey year for Tracking Results Continuously versus Transmission Assessment Surveys. Table S3. Observed seropositivity to P. falciparum antigens by survey year with 95% confidence intervals for community members surveyed for Tracking Results Continuously, 2012-2017. Table S4. Descriptive statistics of survey-site temporal covariates. Table S5. Descriptive statistics of survey-site static covariates. Table S6. Mean estimated coefficients of covariates with 95% credible intervals